Fiche société
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Traitements, essais et publications liés.
Traitements0programmes
Essais2liés
Publications5liées
SourceDBlocale
Traitements
0| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Aucun traitement. | |||||
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SYS6020 injection | Myasthénie | Phase 1 | NCT06688435 | A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis | RECRUITING |
| SYS6020 injection | SEP | Phase 1/2 | NCT07756268 | Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis | NOT_YET_RECRUITING |
Publications
5| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| SYS6020 injection | Delayed Argon Plasma Coagulation After Endoscopic Injection Sclerotherapy for Esophageal Varices Reduces Recurrence Risk. | DEN open | ||
| SYS6020 injection | Recent Development of Endo-hepatology. | DEN open | ||
| SYS6020 injection | Glomerulus-Targeted Nanotherapy via Collagen IV-α3 Binding Enhances Renal Immunoregulation in Lupus Nephritis. | Clinical science (London, England : 1979) | ||
| SYS6020 injection | Lurasidone hydrochloride-loaded microparticle-based long-acting injectable: formulation optimisation, characterisation, and payload release kinetics-a proof of concept study. | Journal of microencapsulation | ||
| SYS6020 injection | Modified clomiphene citrate protocol versus gonadotropin-releasing hormone antagonist protocol in fertilization: a propensity score-matched retrospective study on cost and efficacy. | Frontiers in endocrinology |